Vectura Group PLC (LON:VEC)‘s stock had its “buy” rating reiterated by research analysts at FinnCap in a research report issued to clients and investors on Tuesday. They presently have a GBX 225 ($2.79) price target on the stock. FinnCap’s price objective suggests a potential upside of 52.93% from the stock’s previous close.

Several other research firms also recently issued reports on VEC. JPMorgan Chase & Co. reiterated an “overweight” rating and set a GBX 230 ($2.85) price target on shares of Vectura Group PLC in a research note on Thursday, November 24th. Peel Hunt reiterated a “buy” rating and set a GBX 200 ($2.48) price target on shares of Vectura Group PLC in a research note on Friday, August 5th. N+1 Singer reiterated a “buy” rating and set a GBX 208 ($2.58) price target on shares of Vectura Group PLC in a research note on Tuesday, November 22nd. Numis Securities Ltd upped their price target on Vectura Group PLC from GBX 246 ($3.05) to GBX 252 ($3.13) and gave the stock a “buy” rating in a research note on Monday, September 19th. Finally, Stifel Nicolaus reiterated a “buy” rating and set a GBX 242 ($3.00) price target on shares of Vectura Group PLC in a research note on Tuesday, August 30th. Eight analysts have rated the stock with a buy rating, The stock presently has a consensus rating of “Buy” and an average price target of GBX 222.13 ($2.76).

Analyst Recommendations for Vectura Group PLC (LON:VEC)

Vectura Group PLC (LON:VEC) opened at 146.60 on Tuesday. Vectura Group PLC has a 52-week low of GBX 122.90 and a 52-week high of GBX 200.10. The firm’s market cap is GBX 842.51 million. The company’s 50-day moving average price is GBX 138.77 and its 200-day moving average price is GBX 147.43.

COPYRIGHT VIOLATION NOTICE: “Vectura Group PLC (VEC) Earns Buy Rating from FinnCap” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another site, it was stolen and republished in violation of United States & international copyright & trademark laws. The original version of this report can be read at https://www.thecerbatgem.com/2016/11/29/vectura-group-plc-vec-earns-buy-rating-from-finncap.html.

In other news, insider Trevor Phillips sold 240,841 shares of the stock in a transaction that occurred on Tuesday, September 27th. The stock was sold at an average price of GBX 139 ($1.72), for a total value of £334,768.99 ($415,294.62). Also, insider Andrew Derodra bought 30,000 shares of the company’s stock in a transaction dated Friday, September 30th. The stock was bought at an average cost of GBX 138 ($1.71) per share, with a total value of £41,400 ($51,358.39).

Vectura Group PLC Company Profile

Vectura Group plc is a product development company. The Company focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases (airways diseases). The Company has eight products marketed by its partners and a portfolio of drugs in clinical development, a number of which have been licensed to pharmaceutical companies.

Receive News & Stock Ratings for Vectura Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vectura Group PLC and related stocks with our FREE daily email newsletter.